Alfresa Holdings Corporation (ALFRY)
ALFRY Stock Price Chart
Explore Alfresa Holdings Corporation interactive price chart. Choose custom timeframes to analyze ALFRY price movements and trends.
ALFRY Company Profile
Discover essential business fundamentals and corporate details for Alfresa Holdings Corporation (ALFRY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
3 Jan 2018
Employees
12.52K
Website
https://www.alfresa.comCEO
Ryuji Arakawa
Description
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
ALFRY Financial Timeline
Browse a chronological timeline of Alfresa Holdings Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 4 Aug 2025
EPS came in at $0.19 , while revenue for the quarter reached $5.25B , missing expectations by -99.32%.
Earnings released on 12 May 2025
EPS came in at $0.06 , while revenue for the quarter reached $4.67B , missing expectations by -99.32%.
Earnings released on 6 Feb 2025
EPS came in at $0.40 , while revenue for the quarter reached $5.13B , missing expectations by -99.26%.
Earnings released on 7 Nov 2024
EPS came in at $0.35 , while revenue for the quarter reached $4.94B .
Earnings released on 5 Aug 2024
EPS came in at $0.15 , while revenue for the quarter reached $4.50B .
Earnings released on 14 May 2024
EPS came in at $0.31 , while revenue for the quarter reached $4.47B .
Earnings released on 8 Feb 2024
EPS came in at $0.34 , while revenue for the quarter reached $5.38B .
Earnings released on 30 Sept 2023
EPS came in at $0.27 , while revenue for the quarter reached $4.81B .
Earnings released on 30 Jun 2023
EPS came in at $0.14 , while revenue for the quarter reached $4.91B .
Earnings released on 31 Mar 2023
EPS came in at $0.41 , while revenue for the quarter reached $4.89B .
Dividend declared on 30 Mar 2023
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 6 Jun 2023.
Earnings released on 31 Dec 2022
EPS came in at $0.30 , while revenue for the quarter reached $5.52B .
Earnings released on 30 Sept 2022
EPS came in at $0.17 , while revenue for the quarter reached $4.67B .
Dividend declared on 29 Sept 2022
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 6 Dec 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.08 , while revenue for the quarter reached $4.83B .
Earnings released on 31 Mar 2022
EPS came in at $0.54 , while revenue for the quarter reached $5.07B .
Dividend declared on 30 Mar 2022
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 30 Mar 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.49 , while revenue for the quarter reached $5.88B .
Earnings released on 30 Sept 2021
EPS came in at $0.16 , while revenue for the quarter reached $5.79B .
Dividend declared on 29 Sept 2021
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 29 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.14 , while revenue for the quarter reached $5.79B .
Earnings released on 31 Mar 2021
EPS came in at $0.23 , while revenue for the quarter reached $5.59B .
Dividend declared on 30 Mar 2021
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 1 Jun 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.37 , while revenue for the quarter reached $6.68B .
Earnings released on 30 Sept 2020
EPS came in at $0.24 , while revenue for the quarter reached $6.11B .
Dividend declared on 29 Sept 2020
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 29 Sept 2020.
ALFRY Stock Performance
Access detailed ALFRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.